Josephine Wu is the Chief Investment Officer of Sapere Capital Management Limited, an asset management platform which provides global asset allocation and investment solutions focused on capital appreciation and wealth preservation for families, corporates and entrepreneurs.
Josephine has over 20 years of hedge fund, family office and global asset management experience including over 13 years of listed, pre-IPO and early stage Pan-Asia healthcare investment experience. She has managed multi-billion dollar portfolios with investments across different asset classes globally, especially in the pan-Asia region. Her focus on healthcare sector allows her to contribute on business development and commercialization strategies to various healthcare companies in the Pan-Asia region. She brings in an extensive network of experts in operation, clinical, market positioning and regulatory knowledge in the Pan-Asia healthcare landscape. Her investments in healthcare companies at different stages has led to a few successful commercialization launches of pharmaceutical products, regulatory approvals for decontamination solutions for hospitals and research centers, and the signing of strategic partnerships in commercialization transactions and IPOs.
Previously, she was Head of Asia Absolute return and alternative strategies at UBP; Managing Partner of Light & Salt Capital Management; Regional Portfolio Manager at Robeco HK Limited and Yu Ming Investments and General Partner at L-R Global Partners LP in New York.